Novasign

Description: Novasign uses AI & hybrid modeling to accelerate bioprocess development, reducing time-to-market for new molecules & biosimilars.

Country: Austria

Based in: Vienna

Founded: 2019

Funding Stage: Seed

Tags: ['biotechnology', 'hybrid modeling', 'artificial intelligence', 'industrial']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.